Behind The Counter Debate Raises Questions Of Pharmacist Role In Diagnosis
This article was originally published in The Tan Sheet
Executive Summary
A behind-the-counter class of drugs would inevitably put pharmacists in the position of diagnosing patients' conditions, opponents say
You may also be interested in...
Pharmacy-Based Nonprescription Viagra Sales Expand In U.K.
U.K. pharmacy chain Alliance Boots expanded its program to sell Pfizer's Viagra erectile dysfunction drug without a prescription through pharmacists
FDA Awaits GAO Report To Guide Behind-The-Counter Policy
The Government Accountability Office's anticipated updated report on a behind-the-counter class of drugs will help shape FDA's policy, according to Connie T. Jung, senior policy advisor for Pharmacy Affairs
BTC Proponents Cite Pharmacists’ Role; Opponents Question Need
There is one thing agreed on by opponents and proponents of assigning drugs to behind-the-counter status, including representatives from the pharmaceutical industry, drug retailers, the pharmacy and medical professions, researchers and consumer advocates: FDA will need a long time to reach a decision on the issue, they say